San Diego-based IriSys LLC has raised $6.3 million in equity financing, according to a recent filing with the Securities and Exchange Commission.

The company offers contract pharmaceutical product development and manufacturing services for drug formulations, clinical trial materials, and commercial pharmaceutical products in addition to consulting services related to the drug development process, according to the company website.